Heteromeric Assembly of P2X Subunits
Overview
Affiliations
Transcripts and/or proteins of P2X receptor (P2XR) subunits have been found in virtually all mammalian tissues. Generally more than one of the seven known P2X subunits have been identified in a given cell type. Six of the seven cloned P2X subunits can efficiently form functional homotrimeric ion channels in recombinant expression systems. This is in contrast to other ligand-gated ion channel families, such as the Cys-loop or glutamate receptors, where homomeric assemblies seem to represent the exception rather than the rule. P2XR mediated responses recorded from native tissues rarely match exactly the biophysical and pharmacological properties of heterologously expressed homomeric P2XRs. Heterotrimerization of P2X subunits is likely to account for this observed diversity. While the existence of heterotrimeric P2X2/3Rs and their role in physiological processes is well established, the composition of most other P2XR heteromers and/or the interplay between distinct trimeric receptor complexes in native tissues is not clear. After a description of P2XR assembly and the structure of the intersubunit ATP-binding site, this review summarizes the distribution of P2XR subunits in selected mammalian cell types and the biochemically and/or functionally characterized heteromeric P2XRs that have been observed upon heterologous co-expression of P2XR subunits. We further provide examples where the postulated heteromeric P2XRs have been suggested to occur in native tissues and an overview of the currently available pharmacological tools that have been used to discriminate between homo- and heteromeric P2XRs.
P2X receptors exhibit at least three modes of allosteric antagonism.
Oken A, Ditter I, Lisi N, Krishnamurthy I, Godsey M, Mansoor S Sci Adv. 2024; 10(40):eado5084.
PMID: 39365862 PMC: 11451537. DOI: 10.1126/sciadv.ado5084.
Structural insights into the human P2X1 receptor and ligand interactions.
Bennetts F, Venugopal H, Glukhova A, Mobbs J, Ventura S, Thal D Nat Commun. 2024; 15(1):8418.
PMID: 39341830 PMC: 11439047. DOI: 10.1038/s41467-024-52776-7.
Oken A, Lisi N, Krishnamurthy I, McCarthy A, Godsey M, Glasfeld A Nat Commun. 2024; 15(1):6662.
PMID: 39107314 PMC: 11303814. DOI: 10.1038/s41467-024-50771-6.
Sierra-Marquez J, Schaller L, Sassenbach L, Ramirez-Fernandez A, Alt P, Rissiek B Front Immunol. 2024; 15:1425938.
PMID: 38953020 PMC: 11215518. DOI: 10.3389/fimmu.2024.1425938.
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.
Nagel J, Tormakangas O, Kuokkanen K, El-Tayeb A, Messinger J, Abdelrahman A Purinergic Signal. 2024; 20(6):645-656.
PMID: 38795223 PMC: 11555173. DOI: 10.1007/s11302-024-10005-2.